mapping the effectiveness and risks of glp-1 receptor agonists pdf GLP-1 receptor agonism: a transformative
Description
Subramaniam SR, Chesselet MF
Cardiovascular and kidney benefits of SGLT-2is and GLP-1RAs according to baseline blood pressure in type 2 diabetes: a systematic meta-analysis of cardiovascular outcome trials
Long-term drug therapy and drug discontinuations and holidays for osteoporosis fracture prevention: a systematic review
2019;16(2):e1002744
Initial concerns regarding the possible link between the use of GLP-1 RAs and the development of pancreatitis or pancreatic cancer have not been supported by the results of RCTs [53,54], or real-world data [29,55,56]
Significant elevation of serum dipeptidyl peptidase-4 activity in young-adult type 1 diabetes
